Pfizer To Supply 6M COVID-19 Therapy Courses To Low Income Countries

  • Pfizer Inc PFE would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries.
  • The company said Paxlovid treatment courses would be available for procurement through Global Fund's COVID-19 Response Mechanism to 132 low- and middle-income countries this year, subject to local regulatory clearances.
  • Eligible countries will be offered treatment courses according to Pfizer's tiered pricing approach, where all low- and lower-middle-income countries will pay a not-for-profit price.
  • Also Read: Pfizer's COVID-19 Pill Benefited Only Older Adults, New Israel-Based Study Shows.
  • Additional contractual details of the agreement were not disclosed.
  • Pfizer has made a deal with several generic drugmakers to produce its treatment at a lower price for developing countries.
  • "This agreement with Global Fund is a critical step that will boost equitable access for high-risk patients in low-and-middle-income countries," Chief Executive Officer Albert Bourla said in a statement.
  • Price Action: PFE shares are up 1.24% at $44.47 on the last check Thursday.
  • Photo via Wikimedia Commons
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechLarge CapNewsHealth CareGeneralBriefsCOVID-19 Coronavirus
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!